The treatment of obesity and type 2 diabetes with metabolic surgery influences the physiological role of incretins like GLP-1, GIP, and PYY, which are important players in glucose homeostasis improvement [25]. Here, PYY is linked to obesity due to melanocortin 4 receptor deficiency.